m-Cresol - ipcs inchem
m-Cresol - ipcs inchem
m-Cresol - ipcs inchem
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OECD SIDS<br />
m- / p-CRESOL MIXTURE<br />
5. TOXICITY ID: 15831-10-4<br />
DATE: 24.05.2004<br />
Sex : male/female<br />
Strain : other: F334/N<br />
Route of admin. : oral feed<br />
Exposure period : 13 w<br />
Frequency of treatm. : continuously in feed<br />
Post exposure period : no<br />
Doses : 0, 1880, 3750, 7500, 15000, 30000 ppm (see RM)<br />
Control group : yes, concurrent no treatment<br />
NOAEL : 3750 ppm<br />
Method : other: see freetext ME<br />
Year : 1991<br />
GLP : yes<br />
Test substance : other TS: m-/p-cresol (60%:40% mixture)<br />
Method : SIZE OF STUDY GROUP:<br />
20 male and 20 female rats (10 of each group designated for<br />
clinical pathology studies)<br />
TIME HELD BEFORE STUDY: 12-13 days<br />
METHOD OF ANIMAL DISTRIBUTION:<br />
randomized for each sex on the basis of body weight into<br />
groups per sex<br />
DIET: NIH-07 rat ration<br />
ANIMAL ROOM ENVIRONMENT:<br />
temperature: 72° +/-3° F, humidity: 50 % +/-15 %,<br />
Fluorescent light: 12 hrs/day, room air changes: 10-12<br />
changes/hr<br />
TYPE AND FREQUENCY OF OBSERVATION:<br />
observed twice daily, body weight taken initially, weekly,<br />
and at termination, feed consumption by cage recorded twice<br />
weekly<br />
NECROPSY AND HISTOLOGIC EXAMINATION:<br />
necropsy performed on all animals. A complete<br />
histopathologic examination was conducted on all control<br />
animals, all animals in the highest dose group with at least<br />
60 % survivors at study termination, and all aninmals in<br />
higher dose groups inclusive of early deaths. The following<br />
organs and/or tissues were included in complete<br />
histopathological examinations, as well as any tissue<br />
masses, gross lesions, and associated regional lymph nodes:<br />
adrenals, aorta, bone (sternebrae, femur, or vertebrae,<br />
including marrow), brain, bronchi, clitoral gland,<br />
epididymis, oesophagus, heart, kidney, large intestines<br />
(caecum, colon,rectum), liver, lungs, lymph nodes<br />
(mesenteric), mammary glands, nasal cavity and turbinates,<br />
oral cavity, ovaries, pancreas, parathyroids, pharynx,<br />
pituitary, preputial gland, prostate, salivary glands,<br />
scrotal sac, seminal vesicles, skin, small intestine<br />
(duodenum, ileum, jejunum), spleen, stomach, testes, thymus,<br />
thyroid, tongue, trachea, tunica vaginalis, urinary bladder,<br />
uterus and Zymbal's glands. For lower level dose groups, all<br />
gross lesions and the following target organs were examined<br />
histopathologically: bone marrow, nasal mucosa, thyroid<br />
gland, uterus. Organ weights recorded for brain, liver,<br />
right kidney, thymus, heart, and lungs of all animals, and<br />
the right testis of all males.<br />
HAEMATOLOGIC, CLINICAL CHEMISTRY, and URINALYSIS<br />
determinations included.<br />
haematocrit, haemoglobin, red blood cell count, mean cell<br />
volume (only females), meam cell haemoglobin, mean cell<br />
haemoglobin concentration (only females), platelets,<br />
reticulocytes, white blood cell count, lymphocytes,<br />
354<br />
UNEP PUBLICATIONS